ACE2 and TMPRSS2 were shown to be the key mediators of SARS-CoV-2 viral entry early in the COVID-19 pandemic, but which cells of the upper airway tract express them and mechanisms governing their expression in the lung were not defined (3, 4). This evidence concerns the gene TMPRSS2 and COVID-19.